Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | MLNR | O43193 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834212 | 1.00 | HTT (0.50) | HTTDNM1LMNAHRH3MLNR | |
| SCHEMBL25834216 | 1.00 | HTT (0.50) | HTTDNM1LMNAHRH3MLNR | |
| SCHEMBL5944514 | 0.91 | HTT (0.68) | HTTDNM1LMNAHRH3MLNR | |
| SCHEMBL13714974 | 0.91 | HTT (0.68) | HTTDNM1LMNAHRH3MLNR | |
| SCHEMBL4806690 | 0.91 | HTT (0.68) | HTTDNM1LMNAHRH3MLNR | |
| SCHEMBL4807333 | 0.91 | HTT (0.68) | HTTDNM1LMNAHRH3MLNR | |
| Bromide SCHEMBL5027866 | 0.89 | DNM1 (0.67) | HTTDNM1LMNAHRH3MLNR | |
| Bromide SCHEMBL5547542 | 0.89 | DNM1 (0.67) | HTTDNM1LMNAHRH3MLNR | |
| Hydrochloric Acid SCHEMBL8652995 | 0.89 | HTT (0.65) | HTTDNM1LMNAHRH3MLNR | |
| Bromide SCHEMBL399887 | 0.89 | DNM1 (0.67) | HTTDNM1LMNAHRH3MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | HACD3, C9, HACD2 | HTT 657/4885DNM1 1502/4885LMNA 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.